Artesunate is generally well tolerated.<ref name=NEJM2008>{{cite journal|last1=Rosenthal|first1=Philip J.|title=Artesunate for the Treatment of Severe Falciparum Malaria|journal=New England Journal of Medicine|date=24 April 2008|volume=358|issue=17|pages=1829–1836|doi=10.1056/NEJMct0709050}}</ref> Side effects may include a [[bradycardia|slow heartbeat]], allergic reaction, dizziness, and [[low white blood cell levels]].<ref name=WHO2013/> During [[pregnancy]] it appears to be a safer option, even though animal studies have found harm to the baby.<ref>{{cite journal|last1=Kovacs|first1=SD|last2=Rijken|first2=MJ|last3=Stergachis|first3=A|title=Treating severe malaria in pregnancy: a review of the evidence.|journal=Drug safety|date=February 2015|volume=38|issue=2|pages=165–81|pmid=25556421|doi=10.1007/s40264-014-0261-9|pmc=4328128}}</ref> Use is likely okay during [[breastfeeding]].<ref>{{cite web|title=Artesunate use while Breastfeeding {{!}} Drugs.com|url=https://www.drugs.com/breastfeeding/artesunate.html|website=www.drugs.com|accessdate=7 December 2016|deadurl=no|archiveurl=https://web.archive.org/web/20161220222313/https://www.drugs.com/breastfeeding/artesunate.html|archivedate=20 December 2016|df=}}</ref> It is in the [[artemisinin]] class of medication.<ref name=CDC2012/>

 

